Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-02-03 Sale | 2025-02-05 4:16 pm | Allogene Therapeutics Inc. | ALLO | Douglas Earl Martin SVP, General Counsel | 6,404 | $1.71 | $10,951 | 587,848 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-01-24 Option Award | 2025-01-28 8:16 pm | N/A 2035-01-24 | Allogene Therapeutics Inc. | ALLO | Douglas Earl Martin SVP, General Counsel | 657,298 | $0 | 1,106,622 (Direct) | View |
| 2024-08-21 Tax Withholding | 2024-08-23 4:15 pm | N/A N/A | Allogene Therapeutics Inc. | ALLO | Douglas Earl Martin SVP, General Counsel | 28,310 | $2.785 | 449,324 (Direct) | View |
| 2024-01-25 Option Award | 2024-01-31 5:48 pm | N/A 2034-01-25 | Allogene Therapeutics Inc. | ALLO | Douglas Earl Martin SVP, General Counsel | 189,578 | $0 | 625,412 (Direct) | View |
| 2023-08-14 Option Award | 2023-08-17 6:57 pm | N/A 2033-08-14 | Allogene Therapeutics Inc. | ALLO | Douglas Earl Martin GENERAL COUNSEL | 1,396,688 | $0 | 1,396,688 (Direct) | View |